After the books closed: the quarter's biggest news happened too late to be in the numbers
The model's full reasoning — Q1 2018 call → NOWe need to answer YES or NO based on the transcript. The question asks whether management reports that the most important positive developments of the period happened so late in the reported period or shortly after it ended that the results contain little or none of their effect, with management marking the timing. We need to look for management's own words indicating late-breaking concrete positive events that are treated as the real story the numbers missed. Let's scan the transcript for timing cues. Management discusses various developments: NovaSeq, consumables, microarrays, oncology collaborations, etc. They mention "we launched our iSeq platform in the first quarter and shipped units to customers for beta testing. During the beta test, we identified some opportunities to improve our corporate billing and shipping processes... We are in the process of validating these improvements and expect to scale shipments midyear." That's about iSeq, but it's not a positive late-breaking event; it's a delay. They mention "we announced partnerships with Loxo Oncology and BMS" - these were announced recently, but they are collaborations that will have milestones in the future. They say "Those are multiyear collaborations. We’re kicking them off now. They certainly have milestones that happen over the course of the next couple of years... There was no revenue impact in Q1." So these are announced after the period? Actually, they were announced in the first quarter? The transcript says "our recent announcements with Loxo Oncology and Bristol-Myers Squibb" - so they are recent, but they are not described as having happened at the very end of the period or after. They are described as collaborations that will contribute in the future. The question asks if management treats them as the real story the numbers missed. They say "we are planning some incremental R&D and commercial projects to capitalize on the momentum" and "Milestone payments associated with our recently announced oncology collaborations" are included in guidance. But they don't say that these happened so late that the results contain little or none of their effect. They explicitly say "There was no revenue impact in Q1" and they are included in future guidance. So that's not exactly the situation.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASM | Avino Silver & Gold Mines Ltd. | Q4 2023 | 2024-03-21 | C+ |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| NBTX | Nanobiotix S.A. | Q2 2023 | 2023-09-27 | D |
| SWBI | Smith & Wesson Brands, Inc. | Q1 2023 | 2022-09-08 | C+ |
| YMM | Full Truck Alliance Co. Ltd. | Q2 2022 | 2022-08-25 | C+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| BFIN | BankFinancial Corporation | Q1 2022 | 2022-05-06 | A |
| RNW | ReNew Energy Global Plc | Q2 2022 | 2021-11-18 | C |
| BFI | BurgerFi International, Inc. | Q3 2021 | 2021-11-12 | C |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
OPK · Q1 2022 → YESThe question is: Does management report that the MOST IMPORTANT POSITIVE DEVELOPMENTS of the period happened SO LATE IN THE REPORTED PERIOD, OR SHORTLY AFTER IT ENDED, that the results being presented...YES The transcript shows management treating the ModeX acquisition (announced and closed on the call date, May 9) and the Sema4/GeneDx deal (closed April 29) as major positive developments that occurred after the Q1 period ended. These are framed as key steps toward unlocking value and are highlighted as the "exciting announcement" that changed the call format.
RNW · Q2 2022 → YESThe question is: Does management report that the MOST IMPORTANT POSITIVE DEVELOPMENTS of the period happened SO LATE IN THE REPORTED PERIOD, OR SHORTLY AFTER IT ENDED, that the results being presented...YES The transcript shows management explicitly marking the timing of key positive developments: 400 MW commissioned "since the end of the quarter" (bringing operating capacity to 7 GW today, with another 400 MW scheduled "over the next couple of weeks"), plus the completed Telangana acquisition adding 260 MW.
ASM · Q4 2023 → YESThe question is: Does management report that the MOST IMPORTANT POSITIVE DEVELOPMENTS of the period happened SO LATE IN THE REPORTED PERIOD, OR SHORTLY AFTER IT ENDED, that the results being presented...